Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Insights
Access our ever-expanding library of thought leadership resources for strategic leaders and professionals in biopharma. It’s full of useful content addressing industry challenges, best practices, therapeutic markets, innovative ideas, and forward-looking insights.
Featured eBook
The “Best Practice Organization” and Its Importance for Success in Today’s Biopharma Industry
Learn More >
Blog
Commercializing Gene Therapies: Navigating Complexity to Build Commercial Models That Work (Part III – Cost Drivers)
Blog
Trends in European Healthcare Policy Will Continue to Shape Access to Healthcare in 2023
Whitepaper
Breakfast Club “Bottom Line” #14: Gene Therapy in 2022, an Update on Challenges & Opportunities
Blog
Thoughts from ESMO 2022 (3): TILs as a Potential Therapeutic Modality for Solid Tumors
Whitepaper
US/EU Governance: The Importance of Company Culture and Proven, Real-World Solutions
Whitepaper
Webinar Summary: Making the Journey from R&D to First Launch
Whitepaper
Psychedelics as a Catalyst for a New Mental Healthcare Model
Whitepaper
Webinar – Supply Chains for Cell & Gene Therapies: Orchestrating a Successful Launch & Beyond
Blog
Thoughts from ESMO 2022 (2): Optimal Integration of TIL Therapy in Cancer Treatment
Blog
Psychedelics as a Catalyst for a New Mental Healthcare Model: Part III – The Potential Value of Digital Health
Whitepaper
Medical Affairs Metamorphosis, Part VI: The Changing Face of Stakeholder Engagement
Blog
Psychedelics as a Catalyst for a New Mental Healthcare Model: Part II – The Costs Beyond the Drug
Whitepaper
Snap Recap: Fall 2022 European Biotech Leader Roundtable
Blog
Thoughts from ESMO 2022 (1): Home Brews vs. Brands
Blog
Psychedelics as a Catalyst for a New Mental Healthcare Model: Part I – Background and Emerging Business Models
Blog
Time to Get Away: Blue Matter’s 2022 Summer Meetings
